fulvestrant has been researched along with 4-hydroxyestradiol in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ansell, PJ; Ganjam, VK; Harada, N; Honda, S; Lubahn, DB; Newton, LG; Philips, BJ; Rottinghaus, GE; Welshons, WV | 1 |
| Garber, J; Heulings, R; Lareef, MH; Russo, IH; Russo, J; Russo, PA | 1 |
| Chang, LW; Chang, YC; Ho, CC; Lin, P; Tsai, MH | 1 |
| Jiang, L; Lehmann, L; Wagner, J | 1 |
| Felty, Q; Okoh, VO; Parkash, J; Poppiti, R; Roy, D | 1 |
5 other study(ies) available for fulvestrant and 4-hydroxyestradiol
| Article | Year |
|---|---|
Estrogen receptor-independent catechol estrogen binding activity: protein binding studies in wild-type, Estrogen receptor-alpha KO, and aromatase KO mice tissues.
Topics: Animals; Aromatase; Binding, Competitive; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogens, Catechol; Female; Fulvestrant; Hydroxyestrones; Kidney; Liver; Male; Mice; Mice, Knockout; Ovary; Proteins; Receptors, Estrogen; Substrate Specificity; Tissue Distribution; Uterus | 2004 |
The estrogen antagonist ICI-182-780 does not inhibit the transformation phenotypes induced by 17-beta-estradiol and 4-OH estradiol in human breast epithelial cells.
Topics: Agar; Breast; Cell Cycle; Cell Line; Cell Line, Tumor; Cell Proliferation; Collagen; Dose-Response Relationship, Drug; Drug Combinations; Epithelial Cells; Estradiol; Estrogen Receptor alpha; Estrogens; Estrogens, Catechol; Female; Flow Cytometry; Fulvestrant; G1 Phase; Humans; Laminin; Neoplasm Invasiveness; Phenotype; Proteoglycans; Resting Phase, Cell Cycle | 2005 |
Increase of carcinogenic risk via enhancement of cyclooxygenase-2 expression and hydroxyestradiol accumulation in human lung cells as a result of interaction between BaP and 17-beta estradiol.
Topics: Air Pollutants; Animals; Aryl Hydrocarbon Hydroxylases; Benzo(a)pyrene; Bronchi; Carcinogens, Environmental; Cells, Cultured; Cyclooxygenase 2; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1B1; Dinoprostone; Drug Synergism; Enzyme Activation; Epithelial Cells; Estradiol; Estrogens, Catechol; Fulvestrant; Humans; In Vitro Techniques; Lung; Male; Membrane Proteins; NF-kappa B; Rats; Rats, Sprague-Dawley; Receptors, Estradiol; Up-Regulation | 2007 |
Soy isoflavones decrease the catechol-O-methyltransferase-mediated inactivation of 4-hydroxyestradiol in cultured MCF-7 cells.
Topics: Breast Neoplasms; Catechol O-Methyltransferase; Cell Line, Tumor; Cell Proliferation; Diet; Estradiol; Estrogens, Catechol; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Glycine max; Humans; Models, Biological; Models, Chemical; Receptors, Estrogen | 2008 |
Reactive oxygen species via redox signaling to PI3K/AKT pathway contribute to the malignant growth of 4-hydroxy estradiol-transformed mammary epithelial cells.
Topics: Animals; Azoles; Catalase; Catechols; Cell Cycle Proteins; Cell Proliferation; Cell Transformation, Neoplastic; Collagen; Colony-Forming Units Assay; Dose-Response Relationship, Drug; Epithelial Cells; Estradiol; Estrogens, Catechol; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Isoindoles; Mammary Glands, Human; Mice; Models, Biological; Neoplasm Invasiveness; Organoselenium Compounds; Oxidation-Reduction; Phenotype; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Signal Transduction; Spheroids, Cellular | 2013 |